• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

HHS to Fund Regeneron's Efforts for Antibody Against Ebola

Article

The collaboration will make available 3 fully-humanized monoclonal antibodies to fight the devastating virus.

The US Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response has entered into an agreement with Tarrytown-based Regeneron Pharmaceuticals, Inc to develop a treatment regimen that includes 3 monoclonal antibodies against the Ebola virus.

The company has developed the 3 fully-humanized monclonal antibodies using their propreitory VelociGene and VelocImmune technologies, and will receive $38 million over a 2-year period for further development and manufacturing of the monoclonal antibodies.

Read the associated press release by HHS here.

Related Videos
1 expert is featured in this series.
5 experts are featured in this series.
Dawn Klemow, MD, assistant clinical professor, The University of Texas Southwestern Medical Center
1 expert is featured in this series.
Related Content
Pharmacist helping customer | Image Credit: Gorodenkoff - stock.adobe.com

Insurer-PBM Firms Dominate Medicare Part D Market, Steering Patients to Their Pharmacies

January 17th 2025
Article

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their pharmacies through network exclusions and targeted marketing.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

January 14th 2025
Podcast

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

Listen

Background of H5N1 word,Medical health concept - JUN LI - stock.adobe.com

New Insights Into H5N1 Variability in Human Mutations

January 17th 2025
Article

Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical Research Institute.

Read More

AJMC Managed Care Cast

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

December 31st 2024
Podcast

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

Listen

FDA approval | Image Credit: BHM - stock.adobe.com

FDA Approves Datopotamab Deruxtecan for HR-Positive/HER2-Negative Metastatic Breast Cancer

January 17th 2025
Article

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

Read More

Man donating blood | Image Credit: © New Africa - stock.adobe.com

5 Medications That Defer Blood Donation

January 17th 2025
Article

Experts stress that persons wanting to donate blood should not stop any medications they are on, with some deferrals being permanent and others temporary.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.